Rossari Biotech Limited Stock Bombay S.E.

Equities

ROSSARI

INE02A801020

Specialty Chemicals

Market Closed - Bombay S.E. 06:00:48 2024-04-23 am EDT 5-day change 1st Jan Change
756 INR +0.25% Intraday chart for Rossari Biotech Limited +4.64% -5.41%
Sales 2024 * 18.45B 222M Sales 2025 * 21.26B 255M Capitalization 41.77B 502M
Net income 2024 * 1.32B 15.89M Net income 2025 * 1.62B 19.44M EV / Sales 2024 * 2.26 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 1.97 x
P/E ratio 2024 *
31.6 x
P/E ratio 2025 *
25.7 x
Employees 500
Yield 2024 *
0.4%
Yield 2025 *
0.99%
Free-Float 31.68%
More Fundamentals * Assessed data
Dynamic Chart
Rossari Biotech Limited Appoints Sunil V as Chief Human Resource Officer, Effective April 15, 2024 CI
Rossari Biotech Limited Approves Incorporation of Wholly Owned Subsidiary in Dubai, United Arab Emirates CI
Transcript : Rossari Biotech Limited, Q3 2024 Earnings Call, Jan 23, 2024
Rossari Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Transcript : Rossari Biotech Limited, Q2 2024 Earnings Call, Oct 23, 2023
Rossari Biotech Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Rossari Biotech Limited Appoints Esha Padmanabhan Achan as Additional Director Designated as Non-Executive, Independent Director with Effective October 21, 2023 CI
Rossari Biotech Incorporates Wholly-Owned Subsidiary in Bangladesh MT
Rossari Biotech Limited Announces Intimation of Incorporation of Rossari Bangladesh Limited, Wholly Owned Subsidiary CI
Transcript : Rossari Biotech Limited, Q1 2024 Earnings Call, Jul 31, 2023
Rossari Biotech Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Rossari Biotech Limited Announces Resignation of Melier Castelino as an Independent Director CI
Rossari Biotech Limited Appoints Ms. Aparna Sharma , as A Non-Executive, Independent Director, Effective 29Th April, 2023 CI
Transcript : Rossari Biotech Limited, Q4 2023 Earnings Call, May 02, 2023
INDIA STOCKS-Indian shares open higher ahead of Fed rate decision RE
More news
1 day+0.25%
1 week+4.64%
Current month+12.10%
1 month+10.26%
3 months-7.69%
6 months-7.98%
Current year-5.41%
More quotes
1 week
703.10
Extreme 703.1
761.00
1 month
665.25
Extreme 665.25
761.00
Current year
665.25
Extreme 665.25
838.95
1 year
665.25
Extreme 665.25
903.45
3 years
536.10
Extreme 536.1
1 620.60
5 years
536.10
Extreme 536.1
1 620.60
10 years
536.10
Extreme 536.1
1 620.60
More quotes
Managers TitleAgeSince
Founder 58 96-12-31
Founder 63 96-12-31
Director of Finance/CFO - 23-04-30
Members of the board TitleAgeSince
Director/Board Member 50 23-04-28
Founder 63 96-12-31
Founder 58 96-12-31
More insiders
Date Price Change Volume
24-04-23 756 +0.25% 8,487
24-04-22 754.2 +4.61% 3,490
24-04-19 720.9 -1.87% 5,119
24-04-18 734.6 -0.26% 9,885
24-04-16 736.6 +1.94% 11,252

Delayed Quote Bombay S.E., April 23, 2024 at 06:00 am EDT

More quotes
Rossari Biotech Limited is an India-based company. The Company is engaged in manufacturing, selling and distribution of specialty chemicals. The products cater to global brands in the FMCG sector and find applications in a host of consumer centric products and home and personal care products, textile chemicals, animal health and nutrition and cosmetic products. It operates through three segments: Home, Personal Care and Performance Chemicals (HPPC), Textile Specialty Chemicals (TSC), and Animal Health and Nutrition (AHN). HPPC produces acrylic polymers, manufacturing a sustainable range of products for various applications in the cleaning industry. TSC is focused on providing customers with eco-friendly, sustainable chemical solutions. It provides solutions for pre-treatment, dyeing and printing, finishing, and specialty chemicals for the entire value chain of the textile industry. AHN provides wellness solutions for pet animals and poultry, focusing on their health and performance.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
756.2 INR
Average target price
911.7 INR
Spread / Average Target
+20.57%
Consensus